Causal association of metformin treatment with diverse cardiovascular diseases: a Mendelian randomization analysis.

The MR study discovered from a genetic standpoint that metformin may lower the risk of hypertrophic cardiomyopathy and valvular heart disease, yet it could elevate the risk of myocardial infarction.